Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Does Cannabis Support Neurogenesis in Mood Disorder-Related Brain Areas? 

Posted
Updated
ByMy Patient Advice
Author: Dr. Clarissa Morton, PharmD

The link between cannabis and neurogenesis is an emerging area of research with implications for depression and bipolar disorder. Neurogenesis, the growth of new neurones, occurs mainly in the hippocampus, a brain region tied to memory and emotional regulation. Reduced hippocampal activity is often observed in mood disorders, and for patients with a mental health condition, treatments that stimulate neuronal growth may improve resilience and recovery. 

Cannabinoids, particularly CBD, are being studied for their potential to promote brain plasticity and support new cell growth, though most evidence remains preclinical. 

Can I use Medical Cannabis for Pain Relief?

Cannabis And Brain Growth Pathways 

Exploring cannabis and neurogenesis means understanding how cannabinoids influence hippocampal activity and broader brain plasticity. The following points show the main mechanisms under investigation. 

Hippocampal Neurogenesis and Cannabis 

Animal studies suggest hippocampal neurogenesis and cannabis interactions may boost new neurone formation, potentially offsetting structural changes seen in chronic depression. 

Cannabinoids and Neurogenesis 

Research into cannabinoids and neurogenesis points to CBD’s role in enhancing cell growth while reducing stress-related damage, supporting brain health and emotional balance. 

Mood-Related Neurogenesis 

The idea of mood-related neurogenesis highlights that stimulating new neurons may help stabilise mood and reduce vulnerability to relapse in patients with depression or bipolar disorder. 

In summary, while early evidence suggests cannabis and neurogenesis may be linked, stronger clinical research is needed to confirm these effects in humans with mood disorders. 

For patients interested in how cannabis may influence brain repair, providers like LeafEase can offer consultations tailored to safe and evidence-based use. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Mood Disorders. 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories